Current status of a recombinant antihemophilic factor VIII clinical trial organized by Baxter.
Scharrer
I
I
University Hospital, Frankfurt/Main, FRG.
D000328:Adult; D005169:Factor VIII / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015483:HIV Antibodies / Q000097:blood; D006207:Half-Life; D006801:Humans; D011994:Recombinant Proteins / Q000493:pharmacokinetics / Q000627:therapeutic use*
D015483:HIV Antibodies; D011994:Recombinant Proteins; D005169:Factor VIII